Institutional

27 de July de 2017

São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending

Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial Court understood in a decision on the merits the owner of pending patent applications does not enjoy exclusive rights. The decision may be subject to an appeal.

Click on Download to access the full text of the decision.

See file

Back

Last related news

8 de September de 2025

Kasznar Leonardos takes part in enforcement operation during the NFL game

Kasznar Leonardos’ Brand Protection & Anti-Piracy team was proud to coordinate and implement enforcement measures to curb the illegal trade of unauthorized … Kasznar Leonardos takes part in enforcement operation during the NFL game

Kasznar Leonardos

5 de September de 2025

Priscila Kashiwabara is recognized as Practitioner of the Year by LMG Life Sciences Americas Awards 2025

We are proud to announce that our partner Priscila Kashiwabara was recognized as Practitioner of the Year (Brazil) by the LMG Life … Priscila Kashiwabara is recognized as Practitioner of the Year by LMG Life Sciences Americas Awards 2025

Kasznar Leonardos

29 de July de 2025

Flávia Tremura was recognized as Lexology Legal Influencer

We are pleased to announce that our partner Flávia Tremura has been recognized as a Lexology Legal Influencer in Intellectual Property for … Flávia Tremura was recognized as Lexology Legal Influencer

Flávia Benzatti Tremura Polli Rodrigues